The effect of additional topical cyclosporine or vitamin A on the ocular surface during antiglaucoma medication administration

Ophthalmic Research
Hyun Kyung ChoJung-Il Moon

Abstract

To investigate the effects of topical application of cyclosporine or vitamin A on the ocular surface during the concurrent administration of antiglaucoma drugs. Thirty rabbits were randomized into 5 groups. Group 1 was administered timolol, group 2 received travoprost, group 3 received a travoprost/timolol fixed combination solution, group 4 received timolol and travoprost, and group 5 received timolol, travoprost, and dorzolamide. Each group was divided into a subgroup that received only the antiglaucoma medication (subgroup A), a subgroup that received topical cyclosporine in addition to the antiglaucoma medication (subgroup B), and a subgroup that received topical vitamin A in addition to the antiglaucoma medication (subgroup C). Conjunctival impression cytology specimens were collected at baseline and at weeks 1, 3, and 6. Conjunctival biopsy specimens were collected at week 6. The impression cytologic study results are as follows: statistically significant differences were found between groups 4A and 4B and between groups 4A and 4C at week 6 (p = 0.004, p = 0.006, respectively) and between groups 5A and 5B and between groups 5A and 5C at weeks 3 and 6 (p = 0.006, p = 0.008 at week 3, p = 0.003, p = 0.004 at week 6, respect...Continue Reading

References

Nov 1, 1990·Archives of Ophthalmology·M J LavinR A Hitchings
May 1, 1989·Ophthalmology·A E MaumeneeW R Green
Sep 1, 1988·Ophthalmology·C U RichterI Brill
Dec 1, 1983·Archives of Ophthalmology·J D NelsonJ D Cameron
Nov 1, 1994·Archives of Ophthalmology·D C BroadwayR A Hitchings
Nov 1, 1994·Archives of Ophthalmology·D C BroadwayR A Hitchings
Jan 1, 1997·International Ophthalmology·E TuraçliC Ekinci
Jan 1, 1997·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·T K KobayashiM Usui
Nov 18, 1998·Ophthalmology·M G HattenhauerD T Gray
Jul 11, 2000·European Journal of Ophthalmology·H SelekM Irkeç
Aug 10, 2000·Clinical & Experimental Ophthalmology·M K AriciC Güler
Jan 16, 2002·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·C CostagliolaA Di Giovanni
Oct 9, 2002·Archives of Ophthalmology·Anders HeijlUNKNOWN Early Manifest Glaucoma Trial Group
Apr 12, 2003·Ophthalmology·Philip P Chen
Nov 22, 2005·The British Journal of Ophthalmology·R SinghH S Dua
Oct 25, 2006·International Ophthalmology Clinics·Stephen C Pflugfelder
Aug 13, 2008·Archives of Ophthalmology·Henry D PerryHoward E Savage
Oct 14, 2008·American Journal of Ophthalmology·Eun Chul KimChoun-Ki Joo

❮ Previous
Next ❯

Citations

May 31, 2018·Expert Opinion on Pharmacotherapy·Konstadinos G Boboridis, Anastasios G P Konstas
Jan 21, 2015·Eye & Contact Lens·Amir A Azari, Christopher J Rapuano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis